Cite
HARVARD Citation
Dhakal, B. et al. (2020). Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta‐analysis of phase 3 randomized controlled trials. Cancer. 126 (12), pp. 2791-2801. [Online].